MyFinsight
Home
About
Contact
gtbp: the income statement
Download
Download image
Net loss
attributable to common...
-$3,258K
Change in fair value of
warrant liability
-$232K
Interest income
$36K
Dividends on preferred
stock
$144K
Net loss
-$3,114K
Total other income
(expense), net
$268K
Loss from operations
-$3,382K
Selling, general and
administrative (including...
$2,748K
Research and development
$634K
Back
Back
Income Statement
source: myfinsight.com
GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (GTBP)